SEC Form 4 · accession 0001104659-15-081123
Hepion Pharmaceuticals, Inc. · HEPA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James Sapirstein
Officer — Chief Executive Officer · Director
Period of report
Nov 23, 2015
Accepted (ET)
Nov 24, 2015 · 4:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001583771
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 23, 2015 | P | 2,500 | $1.64 | A | 2,500 | D |
Table II — derivative securities
No Table II lines on this filing.